Permanent cardiac pacemakers have traditionally comprised a surgically implanted subcutaneous pulse generator affixed to at least one transvenous pacing lead. Despite technological advances, implant-related complications and transvenous-lead failure rates have remained high. The Micra Transcatheter Pacing System is a miniaturized single chamber pacemaker that is implanted directly into the right ventricle, eliminating the subcutaneous pocket and creating a leadless pacemaker system. Registry data show an extremely high implant success rate, significantly lower major complication rates than transvenous pacemakers, stable pacing parameters and reliable battery performance. In this review we summarize the available clinical literature and highlight the promising efficacy and safety of the Micra Transcatheter Pacing System.

Download full-text PDF

Source
http://dx.doi.org/10.2217/fca-2018-0077DOI Listing

Publication Analysis

Top Keywords

micra transcatheter
12
transcatheter pacing
12
pacing system
12
pacing
5
design evaluation
4
evaluation micra
4
system
4
system bradyarrhythmia
4
bradyarrhythmia management
4
management permanent
4

Similar Publications

Introduction: The advancement of medical technology has introduced leadless pacemakers (LPMs) as a significant innovation in cardiac pacing, offering potential advantages over traditional ventricular transvenous pacemakers. This report explores the application of LPMs in two patients with complex valvular histories, particularly those with mechanical tricuspid valves.

Case Reports: The first case involves a 60-year-old male with a history of rheumatic heart disease and triple valve replacement who developed a high-grade AV block.

View Article and Find Full Text PDF

Background: Achieving hemostasis of large bore venous access sites can be challenging and time consuming. Closure devices have proven to be superior in achieving hemostasis, reducing time to ambulation and improving patient comfort, compared to manual hemostasis techniques after femoral venous and arterial access. The closure of the jugular vein following large bore access has not been investigated in previous studies.

View Article and Find Full Text PDF

Background: Micra™ VR Transcatheter Pacing System (Micra VR) is a single-chamber transcatheter leadless pacemaker. Absence of leads and subcutaneous pocket reduces or completely eliminates the risk of complications associated with the conventional transvenous pacemakers (TVPM). When compared with TVPM, the leadless technology provides a quicker postimplantation recovery and causes less cosmetic concerns/discomfort providing better patient experiences in the long run.

View Article and Find Full Text PDF

A comparison of procedure-related adverse events between two right ventricular leadless pacemakers.

J Cardiovasc Electrophysiol

December 2024

The Joseph F. Novogratz Family Heart Rhythm Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Article Synopsis
  • - The study compares the safety and device-related issues of two leadless pacemakers in the U.S.: Medtronic Micra VR and Abbott AVEIR VR, focusing on major adverse clinical events (MACE) and device problems during 2022-2024.
  • - Approximately 6,000 AVEIR VR and 10,000 Micra VR implants were registered, with similar rates of MACE and serious procedural complications between the two, indicating comparable safety profiles.
  • - Despite similar safety outcomes, Micra VR had more cases requiring replacement due to unacceptable thresholds, while AVEIR VR experienced more significant device dislodgements, suggesting design-related differences.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!